Parenteral Therapy For Severe Malaria - Form B To Be Completed By The Attending Physician

ADVERTISEMENT

PARENTERAL THERAPY FOR SEVERE MALARIA - FORM B
To be completed by the Attending Physician
1.
Date (D/M/Y):______________
15. Malaria complications (check all that apply):
[ ] Impaired consciousness or coma
2.
Date IV drug requested (D/M/Y):_________________
[ ] Spontaneous bleeding/DIC
[ ] Severe anemia (Hb ≤50 g/L)
3.
Drug requested: [ ] Artesunate [ ] Quinine
[ ] Renal failure (Cr>265 µmol/L or >upper limit for
age for children
4.
Requesting/Attending physician:
[ ] Pulmonary edema/ARDS/resp failure
_____________________________________
[ ] Circulatory collapse/shock (SBP<80mmHg + cold
5.
Requesting site:________________________
extremities)
Province of requesting site:_______________
[ ] Seizures
[ ] Multiorgan failure
6.
Patient initials (first/middle/last):_________________
[ ] Other:____________________________________
Date of birth (D/M/Y):________ Sex: [ ] Male [ ] Female
16. Were there any complications or adverse events related
7.
Date diagnosed (D/M/Y):_____________
to IV antimalarial drug?
[ ] Yes [ ] No
8.
Date given 1
dose of IV drug (D/M/Y):____________
st
If yes, please specify:_____________________________
9.
Patient outcome as of today’s date (check all that apply):
17. Is this program to provide IV malaria therapy helpful
[ ] Alive [ ] Still hospitalized
to you? [ ] Yes [ ] No
[ ] Discharged
Date (D/M/Y):_____________
[ ] Deceased
Date (D/M/Y):_____________
18. Did you consult with a physician through the
Canadian Malaria Network?
10. Hospitalization
[ ] Yes [ ] No
Total days hospitalized:________
Days in ICU:________
19. If yes, was this a beneficial interaction?
[ ] Yes [ ] No
11. Drug utilization
Number of doses of IV drug administered:____________
20. Comments:_______________________________________
Number of vials used:___________
____________________________________________
12. Step-down therapy or second antimalarial (please specify
and give number of DAYS of therapy):
______________________________________________
[ ] Clindamycin
(# days):__________
21. Suggestions to improve the program:_______________
[ ] Doxycycline
(# days):__________
[ ] Malarone
(# days):__________
______________________________________________
[ ] Quinine oral
(# days):__________
[ ] Other (specify):______________ (# days):_________
______________________________________________
13. Number of days until negative smear achieved:_________
______________________________________________
14. Malaria complications (check all that apply):
[ ] Impaired consciousness or coma
Thank you for completing this form.
[ ] Spontaneous bleeding/DIC
Your cooperation is greatly appreciated.
PLEASE COMPLETE AND RETURN TO THE CMN COORDINATING CENTRE
BY E-MAIL: jlevine@ohri.ca OR BY FAX: 613-737-8164 WITHIN 48 HOURS OF IV DRUG
REQUEST.
Parenteral artesunate and quinine are provided by Health Canada’s Special Access Program through the Canada Malaria Network (CMN).

ADVERTISEMENT

00 votes

Related Articles

Related forms

Related Categories

Parent category: Medical
Go